• Reference Citation Analysis
  • v
  • v
  • Find an Article
Download
Number Select Citation Analysis
1 Guo S, Zhou Y, Xie X. Resveratrol inhibiting TGF/ERK signaling pathway can improve atherosclerosis: backgrounds, mechanisms and effects. Biomed Pharmacother 2022;155:113775. [DOI: 10.1016/j.biopha.2022.113775] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
2 Wei Y, Guo Y, Lv S. Research on the progress of Traditional Chinese medicine components and preparations on histone deacetylase inhibitors - Like effects in the course of disease treatment. J Ethnopharmacol 2022;296:115521. [PMID: 35809757 DOI: 10.1016/j.jep.2022.115521] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text]
3 Ferreyra S, Bottini R, Fontana A. Temperature and light conditions affect stability of phenolic compounds of stored grape cane extracts. Food Chem 2022. [DOI: 10.1016/j.foodchem.2022.134718] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
4 Fan S, Hu Y, You Y, Xue W, Chai R, Zhang X, Shou X, Shi J. Role of resveratrol in inhibiting pathological cardiac remodeling. Front Pharmacol 2022;13:924473. [PMID: 36120366 DOI: 10.3389/fphar.2022.924473] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures]  Open
5 Zhang Y, Lu J, Ma Y, Sun L, Wang S, Yue X, Yu J, Xue P. Establishment of fingerprint and mechanism of anti-myocardial ischemic effect of Syringa pinnatifolia. Biomed Chromatogr 2022. [PMID: 35947036 DOI: 10.1002/bmc.5475] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text]
6 Zhang L, Martin G, Mohankumar K, Hampton JT, Liu WR, Safe S. RESVERATROL BINDS NUCLEAR RECEPTOR 4A1 (NR4A1) AND ACTS AS AN NR4A1 ANTAGONIST IN LUNG CANCER CELLS. Mol Pharmacol 2022:MOLPHARM-AR-2021-000481. [PMID: 35680166 DOI: 10.1124/molpharm.121.000481] [Cited by in Crossref: 1] [Cited by in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text]  Open
PrevPage 1 of 1 1Next
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA